Important Safety Information Regarding The Discontinuation Of Sales - Linnefazodone In Canada: Letter To Pharmacists And Wholesalers

Date: 2003-11-05

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

---

Contact
MHPD DPSC

IMPORTANT SAFETY INFORMATION REGARDING THE DISCONTINUATION OF SALES - LinNefazodone IN CANADA: LETTER TO PHARMACISTS AND WHOLESALERS

The following is duplicated text of a letter from Linson Pharma directed to pharmacists and pharmaceutical wholesalers. This notification is further to a Health Professional Communication issued by Linson Pharma on October 2, 2003.

October 2003

Dear Pharmacist / Wholesaler,

Immediate Attention Required
All Lots of LinNefazodone 50 mg, 100 mg, 150 mg, 200 mg

Discontinuation of sales: LinNefazodone (nefazodone HCl)
PRODUCT	STRENGTH	PRODUCT CODE	DIN	UPC
LinNefazodone*	50 mg	122411	02237397	623136000180
LinNefazodone*	100 mg	122511	02237398	623136000197
LinNefazodone*	150 mg	122611	02237399	623136000203
LinNefazodone*	200 mg	122711	02237400	623136000173

^* nefazodone hydrochloride, USP

As mentioned in the enclosed letter, as of November 27, 2003, the sales of LinNefazodone (nefazodone HCl) will be discontinued in Canada. In order to enhance patient safety and allow physicians the opportunity to counsel their patients concerning alternate treatment options, the product should be made available until November 27, 2003, at which time all distribution and dispensing must cease, so that no further sales should occur after November 27, 2003. In order to assist physicians in protecting the well being of their patients during this transition period, these products should be made available until November 27, 2003 and no product should be returned to Linson Pharma (Linson) at this time. Linson will be sending a second letter on November 27+1 day which will include a fax back form to identify all remaining inventory and a product credit form.

Please inform your customers that they should not discontinue taking LinNefazodone without first consulting with their physician. Please immediately refer any customer seeking LinNefazodone to their doctor for consultation.

If you have any questions about this discontinuation of sales, please call our Customer Services at 1-800-267-0005. We regret any inconvenience and appreciate your cooperation.